-
Signature
-
/s/Mark Reinstra Attorney-in-Fact for Christopher Carvalho
-
Issuer symbol
-
RBLX
-
Transactions as of
-
05 May 2025
-
Transactions value $
-
-$936,163
-
Form type
-
4
-
Filing time
-
07 May 2025, 19:42:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Carvalho Christopher |
Director |
C/O ROBLOX CORPORATION, 3150 S. DELAWARE ST., SAN MATEO |
/s/Mark Reinstra Attorney-in-Fact for Christopher Carvalho |
07 May 2025 |
0001834989 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RBLX |
Class A Common Stock |
Options Exercise |
$818 |
+13K |
+1.32% |
$0.06 |
995K |
05 May 2025 |
Direct |
F1, F2 |
| transaction |
RBLX |
Class A Common Stock |
Sale |
-$687K |
-9.53K |
-0.96% |
$72.02 |
986K |
05 May 2025 |
Direct |
F1, F2, F3 |
| transaction |
RBLX |
Class A Common Stock |
Sale |
-$250K |
-3.45K |
-0.35% |
$72.55 |
982K |
05 May 2025 |
Direct |
F1, F2, F4 |
| holding |
RBLX |
Class A Common Stock |
|
|
|
|
|
161K |
05 May 2025 |
See Footnotes |
F5 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RBLX |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-13K |
-14.29% |
$0.00 |
77.9K |
05 May 2025 |
Class A Common Stock |
13K |
$0.06 |
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: